Sources: Isomorphic Labs, an AI-powered drug discovery company spun out of Google DeepMind, is in advanced talks to raise $2B+ led by Thrive Capital (Bloomberg)

Isomorphic Labs, an AI-driven drug discovery firm that originated from Google DeepMind, is reportedly in advanced negotiations to secure over $2 billion in funding, with Thrive Capital leading the investment round. This significant capital influx aims to bolster the company's efforts in revolutionizing the pharmaceutical landscape through artificial intelligence.